Login / Signup

Dual Antiplatelet Therapy Duration in Medically Managed Acute Coronary Syndrome Patients: Sub-Analysis of the OPT-CAD Study.

Sicong MaZaixin JiangMiaohan QiuZhiguo LiLiya BianYi LiYaling Han
Published in: Advances in therapy (2020)
ClinicalTrials.gov identifier, NCT01735305.
Keyphrases
  • acute coronary syndrome
  • antiplatelet therapy
  • percutaneous coronary intervention
  • end stage renal disease
  • chronic kidney disease
  • newly diagnosed
  • ejection fraction
  • coronary artery disease
  • prognostic factors